Altimmune
ALT
ALT
110 hedge funds and large institutions have $467M invested in Altimmune in 2022 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 27 increasing their positions, 31 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
14.47% more ownership
Funds ownership: 77.86% → 92.33% (+14%)
7% more funds holding
Funds holding: 103 → 110 (+7)
13% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 31
Holders
110
Holding in Top 10
7
Calls
$13.1M
Puts
$1.75M
Top Buyers
| 1 | +$35.1M | |
| 2 | +$12M | |
| 3 | +$11.7M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$11M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$10.5M |
Top Sellers
| 1 | -$23.1M | |
| 2 | -$9.34M | |
| 3 | -$6.5M | |
| 4 |
VA
VR Adviser
New York
|
-$4.57M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$3.46M |